September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Drew Moghanaki: Unresectable Tumors Should Not Be Sent Down a Neoadjuvant Pathway at This Time
Sep 9, 2025, 05:46

Drew Moghanaki: Unresectable Tumors Should Not Be Sent Down a Neoadjuvant Pathway at This Time

Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:

“I agree with Erin A Gillaspie that patients with unresectable tumors should not be sent down a neoadjuvant pathway at this time.

I also believe the legal risks are real and tough to defend in a court of law if a patient’s family chooses to sue a medical center for recommending such an approach.”

Drew Moghanaki: Unresectable Tumors Should Not Be Sent Down a Neoadjuvant Pathway at This Time

More posts featuring Drew Moghanaki.